Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients

NCT01543464 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped Diminished rectruitment

Conditions

Malignant Melanoma

Interventions

DRUG: Chemotherapy: Temozolomide

Sponsor

Inge Marie Svane

Collaborators

[object Object]